Michael Behring

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer diagnosisTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2023
BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis.

Sumit Agarwal, Farrukh Afaq, Prachi Bajpai

|Mar 14, 2023
Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic location.

Chirag Patel, Michael Behring, Sameer Al Diffalha

|Jan 27, 2021
Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early Pandemic.

Chandrakumar Shanmugam, Michael Behring, Vishwas Luthra

|Oct 23, 2019
Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.

Michael Behring, Ana I Vazquez, Xiangqin Cui

Pageof 2